These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 19514614

  • 1. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J, Vítovec J, Soucek M, Dusek L, Pavlík T, CORD Invesigators.
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [Abstract] [Full Text] [Related]

  • 2. CORD: COmparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockers.
    Spinar J, Vítovec J, Souček M, Dušek L, Pavlík T, CORD investigators.
    Int J Cardiol; 2010 Oct 08; 144(2):293-4. PubMed ID: 19297039
    [Abstract] [Full Text] [Related]

  • 3. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul 08; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 08; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 08; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 6. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 08; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 7. Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
    Komers R, Simkova R, Kazdova L, Ruzickova J, Pelikanova T.
    J Renin Angiotensin Aldosterone Syst; 2004 Mar 08; 5(1):33-8. PubMed ID: 15136972
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T, Pohl M, Misselwitz J, John U.
    Kidney Blood Press Res; 2009 Mar 08; 32(6):440-4. PubMed ID: 20016211
    [Abstract] [Full Text] [Related]

  • 9. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R, Zhang Y, Zhang M, Li XC, Cai H, Chen WQ, Zhu H, Ge ZM, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3199-204. PubMed ID: 16405840
    [Abstract] [Full Text] [Related]

  • 10. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J, Ceypová K, Kristenová P, Hauser T.
    Vnitr Lek; 2008 Nov 30; 54(11):1031-8. PubMed ID: 19069675
    [Abstract] [Full Text] [Related]

  • 11. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K, Kohno M, Yukiiri K, Masugata H, Wada Y, Takagi Y, Ohmori K.
    Int J Clin Pharmacol Ther; 2001 Oct 30; 39(10):417-22. PubMed ID: 11680666
    [Abstract] [Full Text] [Related]

  • 12. Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
    Grandi AM, Solbiati F, Laurita E, Maresca AM, Nicolini E, Marchesi C, Gianni M, Guasti L, Venco A.
    Am J Hypertens; 2008 Feb 30; 21(2):231-7. PubMed ID: 18174880
    [Abstract] [Full Text] [Related]

  • 13. Adding angiotensin II type 1 receptor blockade to angiotensin-converting enzyme inhibition limits myocyte remodeling after myocardial infarction.
    Kim YK, Mankad S, Kim SJ, Takagi G, Tamura T, Gerdes AM, Bishop SP, Kramer CM.
    J Card Fail; 2003 Jun 30; 9(3):238-45. PubMed ID: 12815575
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
    Montanaro D, Gropuzzo M, Tulissi P, Vallone C, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Bresadola F, Mioni G.
    Transplant Proc; 2005 Mar 30; 37(2):991-3. PubMed ID: 15848600
    [Abstract] [Full Text] [Related]

  • 15. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 30; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 16. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 30; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr 30; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 18. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH, Lyoussi B, Hernández-Hernández R, Velasco M.
    Am J Ther; 2007 Apr 30; 14(4):386-402. PubMed ID: 17667215
    [Abstract] [Full Text] [Related]

  • 19. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS.
    Am Heart J; 2004 Oct 30; 148(4):628-34. PubMed ID: 15459593
    [Abstract] [Full Text] [Related]

  • 20. Effect of angiotensin II type-1 receptor blockers on stable allograft kidneys: prospective randomized study.
    Nouri-Majalan N, Ghafari A, Moghaddasi S.
    Transplant Proc; 2009 Sep 30; 41(7):2832-4. PubMed ID: 19765449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.